Synthesis, isomerization and biological activity of novel 2-selenohydantoin derivatives
- 1 February 2016
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 24 (4) , 802-811
Abstract
No abstract availableKeywords
Funding Information
- Russian Scientific Fund (14-34-00017)
This publication has 36 references indexed in Scilit:
- Small Organoselenium Compounds: More than just Glutathione Peroxidase MimicsAngewandte Chemie International Edition, 2015
- Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal modelsBritish Journal of Cancer, 2014
- Intervention in cyclophosphamide induced oxidative stress and DNA damage by a flavonyl-thiazolidinedione based organoselenocyanate and evaluation of its efficacy during adjuvant therapy in tumor bearing miceEuropean Journal of Medicinal Chemistry, 2014
- Effects of ebselen on ischemia/reperfusion injury in rat brainInternational Journal of Neuroscience, 2014
- Synthesis and Evaluation of Multi-Target-Directed Ligands against Alzheimer’s Disease Based on the Fusion of Donepezil and EbselenJournal of Medicinal Chemistry, 2013
- Simultaneous Targeting of COX-2 and AKT Using Selenocoxib-1-GSH to Inhibit MelanomaMolecular Cancer Therapeutics, 2013
- The Quinoline Imidoselenocarbamate EI201 Blocks the AKT/mTOR Pathway and Targets Cancer Stem Cells Leading to a Strong Antitumor ActivityCurrent Medicinal Chemistry, 2012
- Synthesis and biological activity of novel organoselenium derivatives targeting multiple kinases and capable of inhibiting cancer progression to metastasesEuropean Journal of Medicinal Chemistry, 2012
- Kinase Regulation by Sulfur and Selenium Containing CompoundsCurrent Cancer Drug Targets, 2011
- Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: A good thing?Cancer Treatment Reviews, 2010